New Startup (0-1M TTM Revenue)
Adela will provide an advanced blood test to detect multiple high-morbidity, high-mortality diseases before symptoms occur, and to enable management through the entire care continuum. Adela’s ability to detect many diseases through a single platform with best-in-class performance sets it apart from other liquid biopsy companies.
|DNAMx Canada, Inc 610 University Avenue Toronto, Ontario, M5G 2M9 Canada|
|Adela Canada. Inc. 610 University Avenue Toronto, Ontario, M5G 2M9 Canada|
To request access, simply fill out the form below and we will contact you.